As the full economic implications of these drugs continue to unfold, careful monitoring and analysis will be crucial to understand their overall impact on various sectors of the economy and society at large
Conclusion GLP-1 medications present cost challenges, with monthly expenses often exceeding $1,000 monthly without insurance coverage
While topical application has minimal systemic absorption, the precautionary principle suggests avoiding use during pregnancy unless a healthcare provider approves
This provision requires PBMs to report detailed prescription drug utilization and spending data to most employer health plans, including gross and net spending, out-of-pocket spending, pharmacy reimbursement, and other details related to the plans pharmacy benefit, effective for plan years beginning 30 months after the date of enactment
We expect this trade relationship to deepen given economic imperatives
An approach to renoprotective treatment for patients with type 2 diabetes and CKD, including prescription requirements for finerenone, are outlined in the Figure